Lipid lowering drugs.

This publication has 36 references indexed in Scilit:

• HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
  New England Journal of Medicine, 1988
• Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients
  Atherosclerosis, 1988
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• Bezafibrate
  Drugs, 1987
• Effects of probucol on xanthomata regression in familial hypercholesterolemia
  The American Journal of Cardiology, 1986
• Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect.
  BMJ, 1985
• Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.
  Circulation, 1984
• Ciprofibrate in the therapy of type II hypercholesterolemia A double-blind trial
  Atherosclerosis, 1982
• Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug Regimen
  New England Journal of Medicine, 1981
• Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein Catabolism
  New England Journal of Medicine, 1980